{
    "clinical_study": {
        "@rank": "21844", 
        "arm_group": [
            {
                "arm_group_label": "Usual Care", 
                "arm_group_type": "Active Comparator", 
                "description": "Usual clinic ADHD care"
            }, 
            {
                "arm_group_label": "Usual Care plus Assessment", 
                "arm_group_type": "Experimental", 
                "description": "Usual clinic ADHD care plus the Quotient\u00ae"
            }
        ], 
        "brief_summary": {
            "textblock": "The study goal is to examine whether the use of an objective computerized neuroassessment\n      (the Quotient System) for Attention-Deficit/Hyperactivity Disorder (ADHD) is related to\n      improved outcomes among pediatric patients being assessed and treated for ADHD."
        }, 
        "brief_title": "Effectiveness of the Quotient\u00ae ADHD Assessment in a System of Care", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Attention Deficit and Disruptive Behavior Disorders", 
            "Attention Deficit Disorder With Hyperactivity"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Mental Disorders", 
                "Attention Deficit and Disruptive Behavior Disorders", 
                "Attention Deficit Disorder with Hyperactivity", 
                "Hyperkinesis"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study is a randomized, controlled trial using a 2-phase data collection.  The first\n      phase is the initial assessment for ADHD and includes all patients eligible to be assessed\n      for ADHD as determined by their clinician in the course of usual care. The baseline\n      measurements will be used to compare groups at baseline, and also for longitudinal analyses\n      of medication management.  Patients are randomized at this point. Patients in both treatment\n      arms who then receive an ADHD diagnosis and who start medication for ADHD will be eligible\n      for the second phase of the study:  three follow-up assessments over six months.  Patients\n      who do not have an ADHD diagnosis will not continue in the study, and will be treated by\n      their clinician as usual."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All patients within the specified age range who are English speaking and who are\n             presenting for ADHD assessment are eligible. An additional criterion is consent to be\n             randomized.\n\n        Exclusion Criteria:\n\n          -  Non English speaking\n\n          -  Refusal to participate"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "12 Years", 
            "minimum_age": "6 Years"
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02094612", 
            "org_study_id": "CN-13-1692-H", 
            "secondary_id": "Quotient ADHD"
        }, 
        "intervention": [
            {
                "arm_group_label": "Usual Care plus Assessment", 
                "description": "Patients will be randomized once at the time of ADHD assessment to either usual clinic ADHD care or usual clinic ADHD care plus the Quotient using computer-generated random numbers.", 
                "intervention_name": "Quotient\u00ae", 
                "intervention_type": "Device", 
                "other_name": [
                    "Quotient\u00ae", 
                    "OpTAX"
                ]
            }, 
            {
                "arm_group_label": "Usual Care", 
                "description": "Usual ADHD care as provided by the clinic", 
                "intervention_name": "Usual Clinic ADHD Care", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Attention Deficit and Disruptive Behavior Disorders", 
            "Attention Deficit Disorder with Hyperactivity", 
            "Pediatrics", 
            "Patient Outcome Assessment"
        ], 
        "lastchanged_date": "May 12, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Folsom", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95630"
                    }, 
                    "name": "Kaiser Permanente, Folsom"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roseville", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95661"
                    }, 
                    "name": "Kaiser Permanente, Roseville"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Walnut Creek", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94596"
                    }, 
                    "name": "Kaiser Permanente, Walnut Creek Medical Center"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effectiveness of the Quotient\u00ae ADHD Assessment in a System of Care", 
        "overall_official": {
            "affiliation": "Kaiser Permanente", 
            "last_name": "Cynthia I Campbell, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome measure will be change in the dose of ADHD medication as measured across three followup time points, comparing a Usual Care group and a Quotient test group.  The hypothesis is that patients who receive the Quotient test (the computerized neuroassessment) will reach a stable therapeutic dose of ADHD medication more quickly, compared to Usual Care.", 
            "measure": "Time to therapeutic dose", 
            "safety_issue": "No", 
            "time_frame": "One month, 3 month and six month follow ups"
        }, 
        "reference": [
            {
                "PMID": "15753909", 
                "citation": "Chinchilli VM, Fisher L, Craig TJ. Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge. J Allergy Clin Immunol. 2005 Mar;115(3):592-7."
            }, 
            {
                "PMID": "10836893", 
                "citation": "Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics. Pediatrics. 2000 May;105(5):1158-70. Review."
            }, 
            {
                "PMID": "15629972", 
                "citation": "Foy JM, Earls MF. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Pediatrics. 2005 Jan;115(1):e97-104."
            }, 
            {
                "PMID": "11352293", 
                "citation": "Herrerias CT, Perrin JM, Stein MT. The child with ADHD: using the AAP Clinical Practice Guideline. American Academy of Pediatrics. Am Fam Physician. 2001 May 1;63(9):1803-10."
            }, 
            {
                "PMID": "16135621", 
                "citation": "Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M, Hinshaw S, Vitiello B, Arnold LE, Elliott G, Hechtman L, Newcorn JH, Pelham WE, Swanson J, Wells K. Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry. 2005 Sep;162(9):1628-36."
            }, 
            {
                "PMID": "3567285", 
                "citation": "Lachin JM, Foulkes MA. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics. 1986 Sep;42(3):507-19."
            }, 
            {
                "PMID": "18416664", 
                "citation": "Langberg JM, Froehlich TE, Loren RE, Martin JE, Epstein JN. Assessing children with ADHD in primary care settings. Expert Rev Neurother. 2008 Apr;8(4):627-41. doi: 10.1586/14737175.8.4.627. Review."
            }, 
            {
                "PMID": "15231919", 
                "citation": "Leslie LK, Weckerly J, Plemmons D, Landsverk J, Eastman S. Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings. Pediatrics. 2004 Jul;114(1):129-40."
            }, 
            {
                "PMID": "17556401", 
                "citation": "Leslie LK, Wolraich ML. ADHD service use patterns in youth. J Pediatr Psychol. 2007 Jul;32(6):695-710. Epub 2007 Jun 7. Review."
            }, 
            {
                "PMID": "22947230", 
                "citation": "Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, Arnold LE. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med. 2012 Sep 4;10:99. doi: 10.1186/1741-7015-10-99. Review."
            }, 
            {
                "PMID": "17556402", 
                "citation": "Pelham WE, Foster EM, Robb JA. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. J Pediatr Psychol. 2007 Jul;32(6):711-27. Epub 2007 Jun 7. Review."
            }, 
            {
                "PMID": "6354290", 
                "citation": "Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics. 1983 Jun;39(2):499-503."
            }, 
            {
                "PMID": "12602646", 
                "citation": "Xie H, McHugo G, Drake R, Sengupta A. Using discrete-time survival analysis to examine patterns of remission from substance use disorder among persons with severe mental illness. Ment Health Serv Res. 2003 Mar;5(1):55-64."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02094612"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "ADHD symptomatology measured by the SNAP-IV", 
                "measure": "ADHD Symptomatology", 
                "safety_issue": "No", 
                "time_frame": "1, 3 and 6 months post baseline"
            }, 
            {
                "description": "Academic performance will be measured by student report cards, and converted to a standardized scale", 
                "measure": "Academic Performance", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Six Months"
            }, 
            {
                "description": "Use of pediatric health care services", 
                "measure": "Persistence in Care", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Six Months"
            }, 
            {
                "description": "Sustained use of ADHD medication", 
                "measure": "Medication Adherence", 
                "safety_issue": "No", 
                "time_frame": "Baseline to six months"
            }, 
            {
                "description": "Likert scale single item measure of how satisfied the pediatric patient's parent was with care received", 
                "measure": "Satisfaction with care", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "Use of healthcare services outside of pediatrics, including the emergency room and psychiatric services.", 
                "measure": "Other health services use", 
                "safety_issue": "No", 
                "time_frame": "Baseline to six months"
            }
        ], 
        "source": "Kaiser Permanente", 
        "sponsors": {
            "collaborator": {
                "agency": "Pearson/Clinical Assessment", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Kaiser Permanente", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}